VRTX
Vertex Pharmaceuticals
PEG ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: VRTX
- PEG Ratio
VRTX currently shows a PEG ratio reading of 0.05 as of Jun 22, 2026. Dividing the 27.44 PE ratio by the 545.3% earnings growth rate produces this figure. When compared to the trailing 4-quarter average of 0.04, VRTX's PEG ratio reflects a 33% increase.
VRTX PEG ratio history
A ten years lookback reveals an average PEG ratio of 1.23 for Vertex Pharmaceuticals. Compared to historical data, VRTX's 0.05 PEG ratio represents a drop of 96%. The ten years high came in the Mar 2018 quarter at 7.76, reflecting peak valuation relative to growth. The bottom was reached in the Dec 2018 quarter at 0.03, suggesting attractive value relative to growth during that period.
Vertex Pharmaceuticals PEG ratio by year
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2025 | 0.03 | 29.32 | 843.3% |
| 2024 | N/A | N/A | -114.8% |
| 2023 | 3.49 | 28.96 | 8.3% |
| 2022 | 0.52 | 22.27 | 42.7% |
| 2021 | N/A | 24.16 | -12.9% |
| 2020 | 0.18 | 22.64 | 127.9% |
| 2019 | N/A | 47.81 | -44.4% |
| 2018 | 0.03 | 20.11 | 677.4% |
| 2017 | 0.43 | 141.38 | 330.4% |
| 2016 | N/A | N/A | 80.1% |
| 2015 | N/A | N/A | 26.4% |
| 2014 | N/A | N/A | -58.6% |
| 2013 | N/A | N/A | -296% |
| 2012 | N/A | N/A | -457.1% |
| 2011 | 2.29 | 237.21 | 103.7% |
Vertex Pharmaceuticals PEG ratio by quarter (TTM)
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Mar 2026 | 0.05 | 26.25 | 545.3% |
| Dec 2025 | 0.03 | 29.32 | 843.3% |
| Sep 2025 | 0.03 | 27.37 | 873.5% |
| Jun 2025 | 0.04 | 31.53 | 847.1% |
| Mar 2025 | N/A | N/A | -124.5% |
| Dec 2024 | N/A | N/A | -114.8% |
| Sep 2024 | N/A | N/A | -113.7% |
| Jun 2024 | N/A | N/A | -114.4% |
| Mar 2024 | 1.19 | 26.83 | 22.6% |
| Dec 2023 | 3.49 | 28.96 | 8.3% |
| Sep 2023 | 4.97 | 25.82 | 5.2% |
| Jun 2023 | 5.38 | 26.88 | 5% |
| Mar 2023 | 0.75 | 24.79 | 32.9% |
| Dec 2022 | 0.52 | 22.27 | 42.7% |
| Sep 2022 | 0.44 | 22.62 | 52% |
VRTX average PEG ratio chart
VRTX's PEG ratio today is lower than the 3, 5 and 10-year averages.
PEG comparison
Vertex Pharmaceuticals's PEG of 0.05 is lower than the Healthcare sector and the industry average. Looking at the Healthcare sector average of 0.55, Vertex Pharmaceuticals's PEG is 91% lower.
VRTX EPS growth
VRTX Price vs fair value
VRTX PEG vs peers
Relative to its peer stocks GILD and BMY, VRTX's PEG ratio is lower.
| Stock name | PEG ratio | Market cap |
|---|---|---|
| VRTX Vertex Pharmaceuticals Inc | 0.05 | $118.47B |
| GILD Gilead Sciences Inc | 0.3 | $155.03B |
| BMY Bristol Myers Squibb Co | 0.46 | $111.7B |
| ABBV AbbVie Inc | N/A | $406.38B |
| MRK Merck & Co Inc | N/A | $285.22B |
| JNJ Johnson & Johnson | N/A | $556.77B |
| ENTA Enanta Pharmaceuticals Inc | N/A | $388.78M |
Frequently asked questions
What is Vertex Pharmaceuticals's PEG ratio?
According to Jun 22, 2026 figures, VRTX's PEG ratio stands at 0.05.
What is the 3-year average PEG ratio for Vertex Pharmaceuticals (VRTX)?
VRTX's 3-year PEG ratio average is 1.9.
What is the 5-year average PEG ratio for Vertex Pharmaceuticals (VRTX)?
VRTX's 5-year PEG ratio average is 1.44.
What is the highest PEG ratio for VRTX?
VRTX's PEG ratio topped out at 7.76 during the Mar 2018 quarter - the highest in ten years.
How does the current PEG ratio for VRTX compare to its historical average?
Compared to the 10-year average, VRTX's PEG ratio stands 96% lower.
Why is Vertex Pharmaceuticals's PEG ratio so low?
Strong earnings growth relative to valuation results in VRTX's low PEG ratio of 0.05.
How is VRTX's PEG ratio calculated (Vertex Pharmaceuticals PEG ratio formula)?
To calculate the PEG ratio, take the company's PE ratio and divide by its earnings per share growth (YoY TTM). As of Jun 22, 2026, Vertex Pharmaceuticals has a PE ratio of 27.44. Earnings grew at 545.3% over the TTM period ending Mar 2026. Applying the formula, this gives a PEG ratio of 0.05. PEG RATIO(0.05) = PE RATIO(27.44) / EPS GROWTH(545.3%)
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.